SONMNasdaqTelephone & Telegraph ApparatusFiscal year ends December 31
DNA X, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$3.31+0.04 (+1.22%)
Close on Oct 19, 2026
- Market cap
- $4.47M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$11.25 (−77.27%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $4.47M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$8.55M
- EPS, diluted
- -$9.24
- Book value per share
- -$0.91
- Diluted shares
- 1M
Nine years at a glance
Fiscal years 2017 to 2025 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$4.22M-213.4% YoY
Net income
-$8.55M
EPS, diluted
-$9.24
Free cash flow
–
Reported periodTrailing twelve months